Curcumin protects mice against Concanavalin A-induced hepatitis by inhibiting intrahepatic intercellular adhesion molecule-1 (ICAM-1) and CXCL10 expression

Molecular and Cellular Biochemistry

Volumn 358, Issue 1-2, 2011, Pages 53-60

  Tu, Chuan Tao ^a   Han, Bing ^a   Liu, Hong Chun ^a   Zhang, Shun Cai ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Autoimmune hepatitis; Concanavalin A (Con A); Curcumin; CXCL10; Inflammation; Intercellular adhesion molecule 1(ICAM 1); Lympocyte

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CONCANAVALIN A; CURCUMIN; CXCL10 PROTEIN, MOUSE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; PROTECTIVE AGENT;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MOTION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HEPATITIS; LIVER; MALE; METABOLISM; MOUSE; PATHOLOGY;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CHEMOKINE CXCL10; CONCANAVALIN A; CURCUMIN; CYTOKINES; GENE EXPRESSION REGULATION; HEPATITIS; INTERCELLULAR ADHESION MOLECULE-1; LIVER; MALE; MICE; MICE, INBRED BALB C; PROTECTIVE AGENTS; RNA, MESSENGER;

EID: 84879789194     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0920-4     Document Type: Article

References (32)

1. Liaw YF, Lee CS, Tsai SL et al (1995) T-cell-mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection. Hepatology 22(5):1368-1373
2. Ajuebor MN, Carey JA, Swain MG (2006) CCR5 in T cellmediated liver diseases: what's going on. J Immunol 177(4): 2039-2045
3. Hong F, Jaruga B, Kim WH et al (2002) Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J Clin Invest 110(10):1503-1513
4. Tiegs G, Hentschel J, Wendel A (1992) A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 90(1):196-203
5. Beldi G, Wu Y, Banz Y et al (2008) Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis. Hepatology 48(3):841-852
6. Tagawa Y, Sekikawa K, Iwakura Y (1997) Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. J Immunol 159(3):1418-1428
7. Wolf D, Hallmann R, Sass G et al (2001) TNF-alpha-induced expression of adhesion molecules in the liver is under the control of TNFR1-relevance for concanavalin A-induced hepatitis. J Immunol 166(2):1300-1307
8. Lafdil F, Wang H, Park O et al (2009) Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production. Gastroenterology 137(6):2125-2126
9. Shetty S, Lalor PF, Adams DH (2008) Lymphocyte recruitment to the liver: molecular insights into the pathogenesis of liver injury and hepatitis. Toxicology 254(3):136-146
10. Ajuebor MN, Hogaboam CM, Le T, Proudfoot AE, Swain MG (2004) CCL3/MIP-1alpha is pro-inflammatory in murine T cellmediated hepatitis by recruiting CCR1-expressing CD4(+) T cells to the liver. Eur J Immunol 34(10):2907-2918
11. Kawasuji A, Hasegawa M, Horikawa M et al (2006) L-selectin and intercellular adhesion molecule-1 regulate the development of concanavalin A-induced liver injury. J Leukoc Biol 79(4):696-705
12. Curbishley SM, Eksteen B, Gladue RP, Lalor P, Adams DH (2005) CXCR 3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow. Am J Pathol 167(3):887-899
13. Corson TW, Crews CM (2007) Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell 130(5):769-774
14. Aggarwal BB, Harikumar KB (2009) Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 41(1):40-59
15. Tang Y, Zheng S, Chen A (2009) Curcumin eliminates leptin's effects on hepatic stellate cell activation via interrupting leptin signaling. Endocrinology 150(7):3011-3020
16. Xie L, Li XK, Funeshima-Fuji N et al (2009) Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production. Int Immunopharmacol 9(5):575-581
17. Bozza M, Bliss JL, Maylor R et al (1999) Interleukin-11 reduces T-cell-dependent experimental liver injury in mice. Hepatology 30(6):1441-1447
18. Bonder CS, Norman MU, Swain MG et al (2005) Rules of recruitment for Th1 and Th2 lymphocytes in inflamed liver: a role for alpha-4 integrin and vascular adhesion protein-1. Immunity 23(2):153-163
19. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402-408
20. Siddiqui AM, Cui X, Wu R et al (2006) The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptorgamma. Crit Care Med 34(7):1874-1882
21. Fu Y, Zheng S, Lin J, Ryerse J, Chen A (2008) Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol Pharmacol 73(2):399-409
22. Oo YH, Adams DH (2010) The role of chemokines in the recruitment of lymphocytes to the liver. J Autoimmun 34(1): 45-54
23. Kaneko Y, Harada M, Kawano T et al (2000) Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med 191(1):105-114
24. Mizuhara H, O'Neill E, Seki N et al (1994) T cell activationassociated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 179(5):1529-1537
25. Sugimoto K, Hanai H, Tozawa K et al (2002) Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology 123(6):1912-1922
26. Park S, Murray D, John B, Crispe IN (2002) Biology and significance of T-cell apoptosis in the liver. Immunol Cell Biol 80(1):74-83
27. Scoazec JY, Feldmann G (1994) The cell adhesion molecules of hepatic sinusoidal endothelial cells. J Hepatol 20(2):296-300
28. Jaruga B, Hong F, Kim WH, Gao B (2004) IFN-gamma/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1. Am J Physiol Gastrointest Liver Physiol 287(5):G1044-G1052
29. Li X, Klintman D, Liu Q, Sato T, Jeppsson B, Thorlacius H (2004) Critical role of CXC chemokines in endotoxemic liver injury in mice. J Leukoc Biol 75(3):443-452
30. Simpson KJ, Henderson NC, Bone-Larson CL, Lukacs NW, Hogaboam CM, Kunkel SL (2003) Chemokines in the pathogenesis of liver disease: so many players with poorly defined roles. Clin Sci 104(1):47-63
31. Zeremski M, Petrovic LM, Chiriboga L et al (2008) Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C. Hepatology 48(5):1440-1450
32. Koniaris LG, Zimmers-Koniaris T, Hsiao EC, Chavin K, Sitzmann JV, Farber JM (2001) Cytokine-responsive gene-2/IFNinducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration. J Immunol 167(1):399-406